
July/August 2014—Researchers have for the first time shown that an oncolytic virus, wild-type reovirus, infects and replicates in brain tumors following intravenous administration. Researchers…
May 2014—In March, Biogen learned the FDA would delay its decision on its peginterferon Beta-1a drug, also known as Plegridy, by three months when the agency announced it was extending…
April 2014—Nationwide survey provides a snapshot of “MS in America.”
March 2014—New publication compiles the latest developments in MS research.
March 2014—MS patients may be at increased risk for certain psychiatric and physical comorbidities. Neurologists can help identify and manage these conditions.
January/February 2014—The hypoglossal nerve or twelfth cranial nerve (CNXII) innervates all of the intrinsic and extrinsic muscles of the ipsilateral tongue, except palatoglossus. Therefore, injuri…
September/October 2013—A small Phase I ALS study is getting big results with stem cell treatment.
July/August 2013—A small Phase I trial sees success using patients’ own altered blood cells to fight immune responses in MS. Is this the future of MS therapy?
For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com
Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.
We use cookies to offer a better user experience and to analyze site traffic. To comply with the European General Data Protection Regulation (GDPR), we are implementing a cookie consent manager to provide residents of the EU/EEA with the ability to customize their cookies. Until this is available, your continued use of this site will be deemed as consent to use of cookies.
Continue »